Early in the morning of Feb. 21, Change Healthcare, a company unknown to most Americans that plays a huge role in the U.S. health system, issued a brief statement saying some of its applications were “currently unavailable.”
Tryptamine Therapeutics Limited Appoints David Castle to Its Scientific Advisory Board | Psychedelic Invest
Tryptamine Therapeutics Limited announce the appointment of Professor David Castle to its Scientific Advisory Board (`SAB’). Professor Castle is a leading psychiatric scholar who was